Journal of Clinical Microbiology, December 2000, p. 4305-4309, Vol. 38, No. 12
Departments of Pediatrics1
and Microbiology/Immunology,4
University of Oklahoma Health Sciences Center, Oklahoma City,
Oklahoma 73104; Department of Pediatrics, Division of
Infectious Disease, University of Washington, Seattle, Washington
981052; and Department of Pediatrics and
Communicable Disease, University of Michigan Medical School, Ann
Arbor, Michigan 481093
Received 1 August 2000/Returned for modification 2 September 2000/Accepted 13 September 2000
Stenotrophomonas maltophilia has recently emerged as an
important nosocomial pathogen in immunocompromised patients, in
transplant recipients, and in persons with cystic fibrosis (CF). While
this organism is nonpathogenic in healthy individuals, it is
increasingly associated with morbidity and mortality in susceptible
populations. Recent studies have indicated that for approximately 10%
of CF patients with moderate lung disease, S. maltophilia
can be cultured from respiratory tract secretions. Identification of
S. maltophilia can be problematic, and analysis of isolates
from the Burkholderia cepacia Research Laboratory and
Repository showed that several isolates presumptively identified as
B. cepacia by clinical microbiology laboratories were in
fact S. maltophilia. To overcome the problems associated
with definitive identification, we developed species-specific PCR
(SS-PCR) primers, designated SM1 and SM4, directed to the 23S rRNA
gene, and tested their utility to accurately identify S. maltophilia directly from sputum. The SS-PCR was developed and
tested against a panel of 112 S. maltophilia isolates
collected from diverse geographic locations. To test for specificity,
43 isolates from 17 different species were analyzed. PCR with the SM1-SM4 primer pair and isolated genomic DNA as a template resulted in
amplification of a band from all S. maltophilia isolates
and was uniformly negative for all other species tested, yielding a
sensitivity and a specificity of 100% for the SS-PCR. The utility of
the SS-PCR to directly identify S. maltophilia in sputum
was examined. Thirteen expectorated sputum samples from CF patients were analyzed by SS-PCR. Three samples were PCR positive, in complete concordance with the conventional laboratory culture. Thus, we have
developed an SS-PCR protocol that can rapidly and accurately identify
S. maltophilia isolates and which can be used for the direct detection of this organism in CF patient sputum.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Identification and Detection of
Stenotrophomonas maltophilia by rRNA-Directed PCR
*
Corresponding author. Mailing Address: Department of
Pediatrics, University of Oklahoma Health Sciences Center, CHO 2308, 940 NE 13th St., Oklahoma City, OK 73104. Phone: (405) 271-4401. Fax:
(405) 271-8710. E-mail: Terrence-Stull{at}ouhsc.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|